Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-21-007816

Director sold 171,003 shares at an average $149.11 ($25,497,840)

  • Director disposed of 1,285,027 shares (other)
  • Director acquired 296,161 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2021-02-19 Sale −78,200 $147.79 $11,557,069 261,634 I: show line 1 in the form
Bolzon Bradley J PhD Director 2021-02-19 Sale −23,276 $149.24 $3,473,785 238,358 I: show line 2 in the form
Bolzon Bradley J PhD Director 2021-02-19 Sale −38,132 $150.10 $5,723,773 200,226 I: show line 3 in the form
Bolzon Bradley J PhD Director 2021-02-19 Sale −27,932 $150.99 $4,217,461 172,294 I: show line 4 in the form
Bolzon Bradley J PhD Director 2021-02-19 Sale −3,463 $151.82 $525,752 168,831 I: show line 5 in the form
Bolzon Bradley J PhD Director 2021-02-19 Other disposition −615,607 720,481 I: show line 6 in the form
Bolzon Bradley J PhD Director 2021-02-19 Other acquisition +158,522 158,522 I: show line 7 in the form
Bolzon Bradley J PhD Director 2021-02-19 Other disposition −158,522 0 I: show line 8 in the form
Open-market sales · 171,003 sh · avg $149.11 · $25,497,840
Loading xslF345X03/doc4.xml…